Cargando…

High risk of non-cancer mortality in bladder cancer patients: evidence from SEER-Medicaid

PURPOSE: The objective of this study was to investigate non-cancer causes of death and associated risk factors after bladder cancer (BC) diagnosis. METHODS: Eligible BC patients were obtained from the SEER database. SEER*Stat software 8.3.9.2 was used to calculate the standardized mortality ratios (...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Shunde, Ge, Chengguo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2023
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10423154/ https://www.ncbi.nlm.nih.gov/pubmed/37270459 http://dx.doi.org/10.1007/s00432-023-04867-z

Ejemplares similares

Cardiovascular Mortality Risk in Patients with Bladder Cancer: A Population-Based Study
por: Wang, Shunde, et al.
Publicado: (2022)

Therapeutic responses to chemotherapy or immunotherapy by molecular subtype in bladder cancer patients: A meta-analysis and systematic review
por: Wang, Shunde, et al.
Publicado: (2023)

Prognostic significance of bladder neck involvement in non‐muscle‐invasive bladder cancer: A SEER database analysis with 19,919 patients
por: Zhan, Xiangpeng, et al.
Publicado: (2021)

Cardiovascular mortality by cancer risk stratification in patients with localized prostate cancer: a SEER-based study
por: Luo, Zehao, et al.
Publicado: (2023)

Factors associated with late risks of breast cancer-specific mortality in the SEER registry
por: Leone, José P., et al.
Publicado: (2021)

Long-term cardiovascular mortality risk in patients with bladder cancer: a real-world retrospective study of 129,765 cases based on the SEER database
por: Liao, Jia, et al.
Publicado: (2023)

Risk of Alzheimer’s Disease in Cancer Patients: Analysis of Mortality Data from the US SEER Population-Based Registries
por: Mezencev, Roman, et al.
Publicado: (2020)

Medicaid Expansion and Mortality Among Patients With Breast, Lung, and Colorectal Cancer
por: Lam, Miranda B., et al.
Publicado: (2020)

Risk factors and nomogram for newly diagnosis of bone metastasis in bladder cancer: A SEER-based study
por: Fan, Zhiyi, et al.
Publicado: (2020)

The prediction of cancer-specific mortality in T1 non-muscle-invasive bladder cancer: comparison of logistic regression and artificial neural network: a SEER population-based study
por: Ślusarczyk, Aleksander, et al.
Publicado: (2023)

Correction to: Factors associated with late risks of breast cancer‑specific mortality in the SEER registry
por: Leone, José P., et al.
Publicado: (2021)

SEER-based risk stratification system for patients with primary non-cirrhotic liver cancer
por: Cao, Runmin, et al.
Publicado: (2023)

Trends in colorectal cancer mortality in hispanics: a SEER analysis
por: Barzi, Afsaneh, et al.
Publicado: (2017)

Survival nomogram for high-grade bladder cancer patients after surgery based on the SEER database and external validation cohort
por: Li, Yihe, et al.
Publicado: (2023)

NUF2 is correlated with a poor prognosis and immune infiltration in clear cell renal cell carcinoma
por: Zheng, Baishu, et al.
Publicado: (2023)

Short-term mortality risks among patients with non-metastatic bladder cancer
por: Zhai, Menghe, et al.
Publicado: (2020)

Cardiovascular Mortality in Ovarian Cancer Patients: An Analysis of Patient Characteristics Using the SEER Database
por: Al-Badawi, Ismail Abdulrahman, et al.
Publicado: (2023)

Ethnicity and survival in bladder cancer: a population-based study based on the SEER database
por: Fang, Wei, et al.
Publicado: (2020)

Patterns of treatment in older patients with newly diagnosed advanced bladder cancer: A SEER dataset analysis
por: Kessler, Elizabeth R., et al.
Publicado: (2022)

Association of Medicaid expansion and insurance status, cancer stage, treatment and mortality among patients with cervical cancer
por: Lee, Grace, et al.
Publicado: (2021)

Marital Status and Prognostic Nomogram for Bladder Cancer With Distant Metastasis: A SEER-Based Study
por: Tao, Liangjun, et al.
Publicado: (2020)

A comparison of Medicaid and non-Medicaid obstetrical care in California
por: Howell, Embry M., et al.
Publicado: (1991)

Oral Cancer Prevalence, Mortality, and Costs in Medicaid and Commercial Insurance Claims Data
por: Tranby, Eric P., et al.
Publicado: (2022)

Racial differences in long-term adjuvant endocrine therapy adherence and mortality among Medicaid-insured breast cancer patients in Texas: Findings from TCR-Medicaid linked data
por: Farias, Albert J., et al.
Publicado: (2018)

Predicting specific mortality from laryngeal cancer based on competing risk model: a retrospective analysis based on the SEER database
por: Shen, Yueran, et al.
Publicado: (2023)

Medicaid Expansions: Probing Medicaid’s Filling of the Cancer Genetic Testing and Screening Space
por: Modell, Stephen M., et al.
Publicado: (2022)

Cancer-Specific Survival Outcome in Early-Stage Young Breast Cancer: Evidence From the SEER Database Analysis
por: Liu, Rui, et al.
Publicado: (2022)

Bladder cancer survival nomogram: Development and validation of a prediction tool, using the SEER and TCGA databases
por: Zhang, Ye, et al.
Publicado: (2019)

Conditional survival of trimodal therapy for nonmetastatic muscle‐invasive bladder cancer: A SEER database analysis
por: Shangguan, Wentai, et al.
Publicado: (2022)

Prognostic factors and nomogram for the overall survival of bladder cancer bone metastasis: A SEER-based study
por: Huang, Yu, et al.
Publicado: (2023)

Development and Validation of Nomograms Predicting the 5- and 8-Year Overall and Cancer-Specific Survival of Bladder Cancer Patients Based on SEER Program
por: Wen, Peng, et al.
Publicado: (2023)

Competing mortality in patients diagnosed with bladder cancer: evidence of undertreatment in the elderly and female patients
por: Noon, A P, et al.
Publicado: (2013)

Development and Validation of a Prognostic Model for Predicting Overall Survival in Patients With Bladder Cancer: A SEER-Based Study
por: Wang, Wei, et al.
Publicado: (2021)

Treatment decisions of bladder cancer in patients older than 85 years: a SEER-based analysis 2011–2015
por: Zhu, Jun, et al.
Publicado: (2022)

Prognostic Factors of Survival for High-Grade Neuroendocrine Neoplasia of the Bladder: A SEER Database Analysis
por: Mollica, Veronica, et al.
Publicado: (2022)

Lung Cancer Attributed Mortality Among 316,336 Early Stage Breast Cancer Cases Treated by Radiotherapy and/or Chemotherapy, 2000–2015: Evidence From the SEER Database
por: Abera, Semaw Ferede, et al.
Publicado: (2021)

Timing of Medicaid Enrollment, Late-Stage Breast Cancer Diagnosis, Treatment Delays, and Mortality
por: Xie, Evaline, et al.
Publicado: (2022)

Web-Based Nomograms for Overall Survival and Cancer-Specific Survival of Bladder Cancer Patients with Bone Metastasis: A Retrospective Cohort Study from SEER Database
por: Yang, Sheng, et al.
Publicado: (2023)

Trends in the incidence and mortality of transitional cell carcinoma of the bladder for the last four decades in the USA: a SEER-based analysis
por: Al-Husseini, Muneer J., et al.
Publicado: (2019)

COVID‐19‐related Medicaid enrollment in Medicaid expansion and non‐expansion states
por: Benitez, Joseph A., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_pekqs1klmlbua8jdbi0nfidubo